Blog

What is a fibroscan?

What is a Fibroscan?

With the rising prevalence of liver disease in the U.S., increasing efforts focus on earlier detection and increasing treatment options. Fibroscan is a non-invasive, quick, and painless procedure that is changing the face of liver disease. Here’s more about what a fibroscan is, how it’s done, and why you may benefit from one. Using the

Read More »

Connecting All the Dots of NAFLD

Nonalcoholic fatty liver disease (NAFLD) is a condition that affects people who drink little to no alcohol. NAFLD is growing in prevalence around the world, especially in the United States. NAFLD can lead to nonalcoholic steatohepatitis (NASH)-an aggressive form of NAFLD. NASH is marked by liver inflammation and can eventually progress to advanced scarring (cirrhosis)

Read More »
NASH: Tricks & Truths

NASH: Tricks and Truths

Nonalcoholic steatohepatitis (NASH) was formally defined about 35 years ago. Even after 15 years of research, there is still no cure or FDA-approved therapy to treat it. We’ve learned a great deal about the inner workings of NASH, but many still wonder, “why the slow progress?” Misconceptions, in general, are never helpful, particularly when it

Read More »
Silent Tsunami- Liver Disease in Latinos

Silent Tsunami- Liver Disease in Latinos

In nonalcoholic fatty liver disease (NAFLD), there are significant racial and ethnic disparities coexisting within it. In the United States, however, its prevalence is highest among Hispanics. Liver disease is ripping through the Latino community like a silent tsunami not only in adults but children too. Knowing why Hispanics are at the highest risk and

Read More »